Cerevance Closes $45 Million Series B Financing
April 14, 2020 10:17 ET
|
Cerevance
BOSTON, MA, April 14, 2020 (GLOBE NEWSWIRE) -- Cerevance, a private drug discovery and development company focused on brain diseases, has closed a Series B financing, bringing in $45 million from...
Greystone Provides Financing for $74.5 Million 16-Property Multifamily Portfolio
October 15, 2018 11:52 ET
|
Greystone
Lightstone Group Refinances 1,768 Affordable and Market-Rate Units Across Virginia NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Greystone, a commercial real estate lending, investment, and advisory...
Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
June 26, 2018 09:15 ET
|
Relievant Medsystems, Inc.
Company to open corporate headquarters in Minneapolis, MN MINNEAPOLIS, June 26, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive...
MediSix Therapeutics Launches with USD$20M Series A Financing
May 14, 2018 19:00 ET
|
Lightstone Ventures
SINGAPORE, May 14, 2018 (GLOBE NEWSWIRE) -- MediSix Therapeutics Pte. Ltd., a development-stage cell therapy company creating novel therapeutics to target T-cell leukemia and lymphoma, today...
Atlas Venture, F-Prime Capital Partners and SV Health Investors to Host Symposium Featuring Therapeutics Startup Ideas From World’s Top Academic Research Institutions
April 12, 2018 09:00 ET
|
SV Health Investors
CAMBRIDGE, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- Boston-area venture capital firms Atlas Venture, F-Prime Capital Partners and SV Health Investors have partnered to create Science 2 Startup, an...
Real Estate Attorney Mark Block Returns to MMM as Partner
March 20, 2018 14:53 ET
|
Morris, Manning & Martin, LLP
ATLANTA, March 20, 2018 (GLOBE NEWSWIRE) -- Respected commercial real estate attorney Mark A. Block has joined the Atlanta office of Morris, Manning & Martin as a partner. Block will practice in...
FIRE1 Raises EUR 40 Million in Series C Financing
January 30, 2018 02:00 ET
|
Lightstone Ventures
DUBLIN, Ireland, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Foundry Innovation & Research 1, Ltd. (FIRE1), today announced the close of a Series C financing totaling EUR 40 Million. The financing was led...
Lightstone Ventures Closes New Life Sciences Fund at $250 Million
September 20, 2017 07:27 ET
|
Lightstone Ventures
MENLO PARK, Calif. and BOSTON, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Lightstone Ventures (LSV), a leading global venture capital firm, today announced it has raised $250 million for Lightstone Ventures...
MediSix Therapeutics Signs Exclusive Licensing Agreement with the National University of Singapore
September 11, 2017 19:10 ET
|
Lightstone Ventures
SINGAPORE, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Lightstone Ventures (LSV) today announced that MediSix Therapeutics Pte Ltd., an early-stage cell therapy company developing novel therapeutics to...
Cancer Metabolism Based Therapeutics, 2017-2030
May 29, 2017 05:55 ET
|
Research and Markets
Dublin, May 29, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Cancer Metabolism Based Therapeutics, 2017-2030" report to their offering. ...